|
| |
neuroventures.com Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Biocorporate Search
NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, ...
http://www.bioportfolio.com/biocorporate/BioCorporate_Direct...
|
Making money and opening minds : Article : Nature Biotechnology
Mark Cochran, general manager at NeuroVentures in Charlottesville, Virginia echoes these ... NeuroVentures' Cochran is particularly skeptical of EEGs, ...
http://www.nature.com/nbt/journal/v25/n4/full/nbt0407-377.ht...
|
{1} Receives $15.3 Million In Series A Financing Round - News ...
Sanderling Ventures, NeuroVentures, CDP Capital, Gray Ghost LLC and Bio*One Capital, the investment arm of the Singapore Economic Development Board (EDB),
...
http://www.biospace.com/news_story.aspx?NewsEntityId=1509172...
|
BioPortfolio - www.acumen llc.com
In addition to an ELISA-based diagnostic, Acumen has several therapeutic approaches to stop ADDL-related diseases. NeuroVentures LLC has made a seed .
...
http://www.bioportfolio.com/search/www.acumen_llc.com.html...
|
News: Neurotechnology Industry Organization Launched to Advance ...
... VA) and Neurotech Network (Tampa, FL); venture capital firms NeuroVentures ( Charlottesville, VA) and Technology Partners (Palo Alto, CA); and strategic ...
http://www.genengnews.com/news/bnitem.aspx?name=6899012&chid...
|
BioSpace - Print News Article
... Ventures joined previous investors Bay City Capital, Oxford Bioscience Partners, Technology Partners, Pappas Ventures and Neuro Ventures in the round.
...
http://www.biospace.com/news_print.aspx?NewsEntityId=88657...
|
careers & recruitment : global science career opportunities in ...
... has prompted drug companies to look to start-ups and academia for talent, says Dan O'Connell, venture capitalist at NeuroVentures in Charlottesville, ...
http://www.nature.com/naturejobs/2008/081113/full/nj7219-276...
|
Saegis Pharmaceuticals Receives $3.8 Million From the Stanley ...
... Venture Partners, NeuroVentures, the Stanley Medical Research Institute and Novartis Pharma AG. For more information, visit http://www.saegispharma.com. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
Acumen Pharmaceuticals Inc. Announces Milestone Achievement In ...
NeuroVentures LLC and the Biotechnology Value Fund are investors in the company. Contact: Best Shot Communications Kate Mulligan, 650-375-0756 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=43323...
|
Open Directory - Business: Financial Services: Venture Capital ...
NeuroVentures Fund - Investment focus: companies involved in the development and marketing of drugs, devices, therapeutics, diagnostics and other medical ...
http://www.dmoz.org/Business/Financial_Services/Venture_Capi...
|
|
